OPUS ® MiniChrom ® Pre-packed Column, 5 x 50 mm, 1 mL, AVIPure ® - AAV – Repligen
A pan-affinity resin for efficient AAV purification
Optimizing AAV Manufacture
Production and purification of adeno-associated virus (AAV) at the 50 L scale - WisdomInterface
AVIPure® - AAV Affinity Resins – Repligen
AVIPure® - AAV Affinity Resins – Repligen
Development and Optimization of a Hydrophobic Interaction Chromatography-Based Method of AAV Harvest, Capture, and Recovery: Molecular Therapy Methods & Clinical Development
Small-scale purification of AAV produced with the AAV-MAX system - WisdomInterface
Overcoming Obstacles Downstream Bioprocessing of AAV gene therapy
High-efficiency purification of divergent AAV serotypes using AAVX affinity chromatography - ScienceDirect
Robertas Medutis on LinkedIn: Affinity chromatography resin designed for the purification of…
Characterization of AAV-Specific Affinity Ligands: Consequences for Vector Purification and Development Strategies: Molecular Therapy Methods & Clinical Development
Evaluation and performance of an AAV affinity resin: a CDMO case study
Evaluation of Poros AAVX Pan-Affinity Resin for rAAV purification and cGMP Manufacturing on Vimeo
AAV Purification | Adeno Associated Virus in Gene and Cell Therapy : 이앤씨바이오
AAV Case Study - Using POROS Custom Resins and CaptureSelect Ligand TechnologyBioProcess International
Gene therapy AAV vector purification process | Cytiva
Enhanced AAV downstream processing | Cytiva
AVIPure® AAV Affinity Resins
OVERCOMING OBSTACLES IN DOWNSTREAM BIOPROCESSING OF AAV-BASED GENE THERAPY PRODUCTS - ABL Biomanufacturing
Optimizing AAV Manufacture
Optimizing AAV Manufacture
Characterization of AAV-Specific Affinity Ligands: Consequences for Vector Purification and Development Strategies: Molecular Therapy Methods & Clinical Development
Mitigating the Immunogenicity of AAV-Mediated Gene Therapy with an Immunosuppressive Phosphoserine-Containing Zwitterionic Peptide | Journal of the American Chemical Society
Semirational bioengineering of AAV vectors with increased potency and specificity for systemic gene therapy of muscle disorders | Science Advances